Latest Financial Position News

Biome Australia Limited has reported its first-ever net profit of $433,395 for the half-year ended December 2024, alongside a 47.4% increase in revenue driven by strong sales of its Activated Probiotics.

Big River Industries reported a 3.3% revenue decline and a 26% drop in EBITDA for 1H FY25, reflecting ongoing residential market challenges. Despite this, the company is investing in growth and operational efficiencies, maintaining a cautiously optimistic outlook for FY26 and beyond.

Deterra Royalties Limited reported a solid half-year profit of $63.9 million despite iron ore price pressures, supported by strong production volumes and gold offtake performance. The company declared a fully franked interim dividend of 9.0 cents per share and maintains robust liquidity for strategic investments.

Challenger Limited has reported a robust first half for the 2025 financial year, with net profit after tax climbing 28.2% and an 11.5% increase in its interim dividend, signaling strong momentum in its financial services operations.

Reliance Worldwide Corporation Limited reported a solid 14.8% increase in net sales for the first half of FY25, driven by the Holman acquisition and organic growth, yet signals a cautious outlook for the remainder of the year amid persistent macroeconomic headwinds.

Reliance Worldwide Corporation posts a robust 14.8% sales increase and a 31.8% jump in net profit for H1 FY25, driven by the Holman acquisition and solid cost efficiencies.

Propell Holdings Limited reported a 75% surge in revenue driven by a rapidly expanding loan book, yet losses more than doubled amid rising impairments. The company is navigating growth challenges while engaging with the ASX on potential delisting.

Citigroup Global Markets Australia has announced a 45-cent unfranked dividend for its CitiFirst Self-Funding Instalment MINIs, with key dates aligned to CPU ordinary shares. The dividend will reduce outstanding loan amounts for MINI holders, impacting their financial positions.

Noble Helium Limited has announced a sweeping board and executive reshuffle following pressure from major shareholders, signaling a strategic reset aimed at strengthening its financial footing and advancing its Tanzanian helium projects.

Health and Plant Protein Group Limited reported a significantly reduced net loss of $43,000 for the half-year ended December 31, 2024, compared to a $748,000 loss in the prior period, despite no operational revenue following the sale of its macadamia division.

The Star Entertainment Group has received a $650 million debt refinancing proposal from Oaktree Capital Management, offering a potential boost to its liquidity but shadowed by significant conditions and uncertainty.

PYC Therapeutics has launched a A$145.8 million pro-rata accelerated non-renounceable entitlement offer to fund late-stage clinical trials across its pipeline targeting rare diseases with high unmet needs. The capital raise aims to extend the company’s cash runway beyond FY27, supporting four drug candidates through critical human safety and efficacy milestones.